VIRALGEN
Viralgen provides AAV manufacturing, development, and validation services. They provide products based on genetic medicines, serotypes, multiple chimeric, and novel capsids. They also provide cGMP gene therapy manufacturing for clinical trials.
VIRALGEN
Social Links:
Industry:
Biotechnology Health Care Manufacturing Pharmaceutical
Founded:
2017-01-01
Address:
San Sebastian, Pais Vasco, Spain
Country:
Spain
Website Url:
http://www.viralgenvc.com
Total Employee:
251+
Status:
Active
Contact:
+34 943 47 77 33
Technology used in webpage:
Domain Not Resolving Google Maps Microsoft Microsoft Azure IONOS Microsoft Azure Europe North Region Telefonica
Similar Organizations
Lavida Nutraceuticals
Lavida Nutraceuticals is a TGA registered therapeutic goods manufacturer located in NSW Australia.
LEO Pharma
Leo Pharma is a multinational Danish pharmaceutical company.
Longevity Biotech
Longevity Biotech develops a new class of therapeutics via artificial protein technology that focuses on pharmaceutical preparation.
LucasPye BIO
A Contract Development and Manufacturing Organization (CDMO) that manufactures protein-therapeutic and viral-therapeutic drug products.
Meitheal Pharmaceuticals
Meitheal Pharmaceuticals specializes in research, manufacturing, and supply of injection medicine.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Nonacus
Nonacus is a medical products manufacturing company that offers non-invasive diagnostic tools.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Veranova
Veranova develops and manufactures pharmaceutical ingredients.
WuXi Advanced Therapies
Contract Development and Manufacturing Organization (CDMO) plus integrated Laboratory Testing Service Platforms
Current Advisors List
Key Employee Changes
| Date | New article |
|---|---|
| 2022-12-22 | Viralgen Announces Javier Garcia as Board Chairman and Jimmy Vanhove as New Chief Executive Officer |
Official Site Inspections
http://www.viralgenvc.com Semrush global rank: 4.21 M Semrush visits lastest month: 2.38 K
- Host name: 199.60.103.122
- IP address: 199.60.103.122
- Location: Canada
- Latitude: 43.6319
- Longitude: -79.3716
- Timezone: America/Toronto
More informations about "Viralgen"
Viralgen | All-in AAV
Jul 28, 2025 Scale your innovation with help from the world leader in AAV-based gene therapy manufacturing.See details»
Viralgen - Crunchbase Company Profile & Funding
Viralgen provides AAV manufacturing, development, and validation services. They provide products based on genetic medicines, serotypes, multiple chimeric, and novel capsids. They โฆSee details»
Viralgen - Overview, News & Similar companies | ZoomInfo.com
Oct 23, 2023 View Viralgen (www.viralgenvc.com) location in Basque Country, Spain , revenue, industry and description. Find related and similar companies as well as employees by title and โฆSee details»
Contact - Viralgen
Our Facilities VIRALGEN VECTOR CORE Paseo Mikeltegi, 83 Parque Científico y Tecnológico de Gipuzkoa, 20009 San Sebastiaฬn, Spain โฆSee details»
Viralgen Company Overview, Contact Details & Competitors | LeadIQ
Learn more about Viralgen's company details, contact information, competitors, and more. Find accurate contact data easily with LeadIQ. Book a demo today.See details»
Viralgen Joins Orphan Therapeutics Accelerator Clinical โฆ
May 14, 2025 Boston, MA & San Sebastian, Spain - May 14, 2025 โ Orphan Therapeutics Accelerator (OTXL), a non-profit biotech dedicated to advancing therapies for ultra-rare โฆSee details»
Viralgen collaborates with Trogenix to advance AAV gene therapy โฆ
May 6, 2025 Viralgen accelerates clinical development process: scaling manufacturing and completing GMP production of Trogenixโs AAV gene therapy in under 12 months. San โฆSee details»
Viralgen - PharmaSource
Viralgen Viralgen Vector Core is a leading Contract Manufacturing Organisation (CMO) and Contract Development and Manufacturing Organisation (CDMO) specialising in the production โฆSee details»
Viralgen - LinkedIn
Viralgen | 14,175 followers on LinkedIn. All-in on AAV gene therapy manufacturing that empowers innovators to bring more potential cures to โฆSee details»
Viralgen and CTNNB1 Foundation partner to manufacture a new โฆ
Feb 5, 2025 Viralgen & the CTNNB1 Foundation partner to develop a groundbreaking gene therapy for CTNNB1 Syndrome, aiming to restore gene function & improve patients' quality of life.See details»
Viralgen Announces Javier Garcia as Board โฆ
Dec 22, 2022 Viralgen, an independently operated Contract Development and Manufacturing Organization (CDMO), was founded in 2017 as a joint โฆSee details»
Viralgen - Profiles & Contacts - Crunchbase
Founded 2017Private San Sebastian, Pais Vasco, Spain 251-500 viralgenvc.com Biotechnology Health Care Manufacturing Pharmaceutical Viralgen Section: People Actions Company Profile โฆSee details»
Who We Are - Viralgen
The people and purpose behind Viralgen, the proven leader in AAV-based gene therapy manufacturing.See details»
Viralgen receives cGMP certification to produce rAAV commercial โฆ
Jan 9, 2023 Viralgen is now licensed for the commercial manufacturing of recombinant adeno-associated virus (rAAV) gene therapies up to 2,000 liters and has completed seven successful โฆSee details»
Viralgen partners with Vallabh/Minikel Lab and Deverman Lab at โฆ
Jan 21, 2025 Discover how Viralgen, the Vallabh/Minikel Lab, & Deverman Lab at the Broad Institute are advancing AAV gene therapy manufacturing to tackle prion disease through โฆSee details»
Viralgen receives cGMP certification to produce rAAV commercial โฆ
Jan 9, 2023 -- Certification expands Viralgen's capacity threefold and positions the company as a world-leading CDMO ---- New facility operates single-use bioreactors from 50 to 2,000 liters โฆSee details»
Viralgen Company Profile | Management and Employees List
Based at the Miramon Parke in San Sebastián, Spain, Viralgen is a CDMO (Contract Development and Manufact uring Organization) that produces AAV gene therapy treatments to โฆSee details»
Viralgen - Home
Information Security Policy This information security policy is approved by Viralgen's Management in order to reinforce the awareness of all Viralgen's members about the threats that may arise. โฆSee details»
Viralgen - VentureRadar
"Viralgen is a leading CDMO specializing in the manufacturing of recombinant adeno-associated virus (rAAV) vectors for gene therapy. The company focuses exclusively on AAV production, โฆSee details»
Axovant and Viralgen Sign Strategic Gene Therapy Partnership
10 de September de 2020 NEW YORK and BASEL, Switzerland, Sept. 15, 2020 -- Axovant Gene Therapies Ltd (NASDAQ: AXGT), a clinical-stage company developing innovative gene โฆSee details»